Kadmon Holdings Inc (NASDAQ:KDMN)‘s stock had its “buy” rating restated by equities researchers at Jefferies Group in a research note issued on Thursday. They currently have a $10.00 target price on the stock, down from their previous target price of $12.00. Jefferies Group’s target price would indicate a potential upside of 52.44% from the company’s current price.

Several other brokerages also recently issued reports on KDMN. Citigroup Inc. initiated coverage on shares of Kadmon Holdings in a report on Monday, August 22nd. They issued a “neutral” rating and a $12.00 price target on the stock. JMP Securities initiated coverage on shares of Kadmon Holdings in a report on Monday, August 22nd. They issued an “outperform” rating and a $16.00 price target on the stock. WBB Securities initiated coverage on shares of Kadmon Holdings in a report on Monday, August 1st. They issued a “sell” rating and a $7.50 price target on the stock. Finally, HC Wainwright initiated coverage on shares of Kadmon Holdings in a report on Monday, August 22nd. They issued a “buy” rating and a $25.00 price target on the stock. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $14.10.

Analyst Recommendations for Kadmon Holdings (NASDAQ:KDMN)

Kadmon Holdings (NASDAQ:KDMN) opened at 6.56 on Thursday. The company’s 50 day moving average is $6.28 and its 200-day moving average is $7.86. Kadmon Holdings has a 52-week low of $4.44 and a 52-week high of $10.48. The stock’s market cap is $214.37 million.

Kadmon Holdings (NASDAQ:KDMN) last announced its quarterly earnings results on Wednesday, November 9th. The company reported ($4.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.40) by $3.83. The business had revenue of $5.70 million for the quarter, compared to the consensus estimate of $3.90 million. The company’s quarterly revenue was down 49.6% on a year-over-year basis. On average, equities analysts anticipate that Kadmon Holdings will post ($4.48) earnings per share for the current year.

In other news, major shareholder Daniel S. Loeb acquired 81,781 shares of the business’s stock in a transaction dated Tuesday, September 6th. The stock was acquired at an average price of $9.39 per share, with a total value of $767,923.59. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Daniel S. Loeb acquired 32,916 shares of the business’s stock in a transaction dated Friday, August 26th. The stock was purchased at an average cost of $9.98 per share, with a total value of $328,501.68. The disclosure for this purchase can be found here.

Several institutional investors have recently bought and sold shares of KDMN. KCG Holdings Inc. bought a new position in shares of Kadmon Holdings during the third quarter valued at approximately $102,000. California State Teachers Retirement System bought a new position in shares of Kadmon Holdings during the third quarter valued at approximately $126,000. BlackRock Institutional Trust Company N.A. bought a new position in shares of Kadmon Holdings during the third quarter valued at approximately $129,000. Beach Point Capital Management LP bought a new position in shares of Kadmon Holdings during the third quarter valued at approximately $1,480,000. Finally, Morgan Stanley bought a new position in shares of Kadmon Holdings during the third quarter valued at approximately $2,180,000.

About Kadmon Holdings

Kadmon Holdings, Inc, formerly Kadmon Holdings, LLC, is a biopharmaceutical company, which is engaged in the discovery, development and commercialization of small molecules and biologics. The Company is developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases.

5 Day Chart for NASDAQ:KDMN

Receive News & Stock Ratings for Kadmon Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon Holdings Inc and related stocks with our FREE daily email newsletter.